If this were any other time in history, these Big Pharma manufacturers’ CEOs and others would have been arrested, prosecuted and executed, along with numerous other people who have broken the law and engaged in the lawlessness that is now called the CONvid-1984 plandemic. Now, a regional director, who was employed at the research organization Ventavia Research Group, has come forward to claim that her company falsified data, unblinded patients, and employed inadequately trained vaccinators. She also claims that the company was extremely slow to follow up on adverse effects in the phase III trials of the Pfizer COVID shot.
- A Pound Of This Gives Your Body Everything You Need & With Promo Code SONSOFLIBERTY You’ll Save $$$
- Pull Your Kids From Public Schools & Educate Them Yourself
- How To Protect Yourself From 5G, EMF & RF Radiation
- Here’s A Way You Can Stockpile Food For The Future
- Preparing Also Means Detoxifying – Here’s One Simple Way To Detoxify
Brook Jackson is the woman who is blowing the whistle on just how badly this “product” was put out and how it appears that there is no standard ever given to the Pfizer COVID shot, which appears largely responsible for the deaths of tens of thousands of Americans, if not millions nation and world wide.
Take a listen.
The BMJ reports:
In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1
But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson (video 1), emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
Poor laboratory management
On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues. Jackson was a trained clinical trial auditor who previously held a director of operations position and came to Ventavia with more than 15 years’ experience in clinical research coordination and management. Exasperated that Ventavia was not dealing with the problems, Jackson documented several matters late one night, taking photos on her mobile phone. One photo, provided to The BMJ, showed needles discarded in a plastic biohazard bag instead of a sharps container box. Another showed vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants. Ventavia executives later questioned Jackson for taking the photos.
Early and inadvertent unblinding may have occurred on a far wider scale. According to the trial’s design, unblinded staff were responsible for preparing and administering the study drug (Pfizer’s vaccine or a placebo). This was to be done to preserve the blinding of trial participants and all other site staff, including the principal investigator. However, at Ventavia, Jackson told The BMJ that drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel. As a corrective action taken in September, two months into trial recruitment and with around 1000 participants already enrolled, quality assurance checklists were updated with instructions for staff to remove drug assignments from charts.
- Pfizer CEO Albert Bourla Claims Fourth Booster & Yearly mRNA Injections Needed Despite Lack Of Safety Or Effectiveness
- Confidential Pfizer Docs: “COVID-19 Vaccine-Associated Enhanced Disease Is A Real Possibility” – Data Proves It’s Already Happening
- New Study Shows Pfizer mRNA Shot Becomes DNA In Just 6 Hours (Video)
- Here’s The Data On Pfizer’s COVID Shot Effecting Children’s Deaths – It’s Chillling!
In a recording of a meeting in late September2020 between Jackson and two directors a Ventavia executive can be heard explaining that the company wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality control. “In my mind, it’s something new every day,” a Ventavia executive says. “We know that it’s significant.”
Ventavia was not keeping up with data entry queries, shows an email sent by ICON, the contract research organisation with which Pfizer partnered on the trial. ICON reminded Ventavia in a September 2020 email: “The expectation for this study is that all queries are addressed within 24hrs.” ICON then highlighted over 100 outstanding queries older than three days in yellow. Examples included two individuals for which “Subject has reported with Severe symptoms/reactions … Per protocol, subjects experiencing Grade 3 local reactions should be contacted. Please confirm if an UNPLANNED CONTACT was made and update the corresponding form as appropriate.” According to the trial protocol a telephone contact should have occurred “to ascertain further details and determine whether a site visit is clinically indicated.”
There were also obviously concerns of the lack of Food and Drug Administration oversight. However, the reality is that the FDA is so corrupt that its former heads are all taking spots in positions in Big Pharma such as Moderna and Pfizer.
The BMJ went on to report:
In her 25 September email to the FDA Jackson wrote that Ventavia had enrolled more than 1000 participants at three sites. The full trial (registered under NCT04368728) enrolled around 44 000 participants across 153 sites that included numerous commercial companies and academic centres. She then listed a dozen concerns she had witnessed, including:
Participants placed in a hallway after injection and not being monitored by clinical staff
Lack of timely follow-up of patients who experienced adverse events
Protocol deviations not being reported
Vaccines not being stored at proper temperatures
Mislabelled laboratory specimens, and
Targeting of Ventavia staff for reporting these types of problems.
Within hours Jackson received an email from the FDA thanking her for her concerns and notifying her that the FDA could not comment on any investigation that might result. A few days later Jackson received a call from an FDA inspector to discuss her report but was told that no further information could be provided. She heard nothing further in relation to her report.
In Pfizer’s briefing document submitted to an FDA advisory committee meeting held on 10 December 2020 to discuss Pfizer’s application for emergency use authorisation of its covid-19 vaccine, the company made no mention of problems at the Ventavia site. The next day the FDA issued the authorisation of the vaccine.8
In August this year, after the full approval of Pfizer’s vaccine, the FDA published a summary of its inspections of the company’s pivotal trial. Nine of the trial’s 153 sites were inspected. Ventavia’s sites were not listed among the nine, and no inspections of sites where adults were recruited took place in the eight months after the December 2020 emergency authorisation. The FDA’s inspection officer noted: “The data integrity and verification portion of the BIMO [bioresearch monitoring] inspections were limited because the study was ongoing, and the data required for verification and comparison were not yet available to the IND [investigational new drug].”
Jackson was not alone in what she witnessed. According to The BMJ, there were at least two former employees that confirmed what Jackson said to be true.
“I’ve never had to do what they were asking me to do, ever,” one of those people told The BMJ. “It just seemed like something a little different from normal—the things that were allowed and expected.”
She also said that a federal audit of Ventavia was expected but it never came.
The former employee also said that the data Ventavia produced for the Pfizer trial was “good, clean data” and that it was “a crazy mess.”
The second former employee said the environment she found herself in at Ventavia was unlike anything that she had experienced in her 20 years of research.
She told The BMJ that, shortly after Ventavia fired Jackson, Pfizer was notified of problems at Ventavia with the vaccine trial and that an audit took place.
One former official for the company stated, “Everything that you complained about was spot on.”
So, what has this produced? The BMJ concludes:
Since Jackson reported problems with Ventavia to the FDA in September 2020, Pfizer has hired Ventavia as a research subcontractor on four other vaccine clinical trials (covid-19 vaccine in children and young adults, pregnant women, and a booster dose, as well an RSV vaccine trial; NCT04816643, NCT04754594, NCT04955626, NCT05035212).
- Conflict Of Interest: Former FDA Commissioners Are Employed At All 3 FDA-Authorized COVID Shot Companies
- Former FDA Commissioners Margaret Hamburg, MD & Scott Gottlieb, MD – Partners in Crime with Anthony Fauci, MD?
- Not Only Are Former FDA Commissioners Working For Vaxx Makers, But FDA Committee Members Reviewing Kids Shots Worked For Pfizer Or Have Pfizer Connections
- The Conflicts Of Interest Between The Unconstitutional FDA & Big Pharma Are Deadly (Video)
- The Conflicts Of Interest At The FDA – It Does Effect You!
And why wouldn’t they? They are literally getting away with murder!
It’s time to rain down justice on those operating these criminal companies.
Become an insider!
Sign up to get breaking alerts from Sons of Liberty Media.